Esplora temi rilevanti sulla Ematologia e sul Trapianto di Midollo Osseo con esperti della Scuola Paulista di Medicina e dell'Ospedale 9 di Luglio.
58 - Ibrutinib plus venetoclax in relapsed or refractory mantle cell lymphoma (SYMPATICO): a multicentre, randomised,double-blind, placebo controlled, phase 3 study
S1 E58 • 34 mins • Jul 13, 2025
Charts
This show is not currently ranked in any charts.
Episodi recenti
Jul 13, 2025
58 - Ibrutinib plus venetoclax in relapsed or refractory mantle cell lymphoma (SYMPATICO): a multicentre, randomised,double-blind, placebo controlled, phase 3 study
S1 E58 • 34 mins
Jul 6, 2025
57 - A randomized phase 2 trial of oral vitamin A for graft-versus-host disease in children and young adults
S1 E57 • 30 mins
Jun 29, 2025
56 - Fixed-Duration Ibrutinib-Venetoclax in Patients with Chronic Lymphocytic Leukemia and Comorbidities
S1 E56 • 35 mins
Jun 22, 2025
55 - Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
S1 E55 • 37 mins
Jun 2, 2025
54 - Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell–Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial
S1 E54 • 40 mins
Lingua
Portoghese
Paese
Brasile
Feed Host
Sito web
Feed
Richiedi un aggiornamento
Gli aggiornamenti potrebbero richiedere alcuni minuti.